Anupam Rama Maintained (ATRA) at Buy with Decreased Target to $550 on, Mar 28th, 2022
Anupam Rama of JP Morgan, Maintained "Atara Biotherapeutics, Inc." (ATRA) at Buy with Decreased Target from $675 to $550 on, Mar 28th, 2022.
Anupam, nor any peers, have made any analyst calls on ATRA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30